Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Subscribe To Our Newsletter & Stay Updated
